Neuroimaging characteristics of dementia with Lewy bodies

Alzheimer's Research and Therapy

Volumn 6, Issue 2, 2014, Pages

  Mak, Elijah ^a   Su, Li ^a   Williams, Guy B ^b   O'Brien, John T ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BIOLOGICAL MARKER; CHOLINESTERASE INHIBITOR; CYSTEINE ETHYL ESTER TC 99M; DOPAMINE TRANSPORTER; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IOFETAMINE I 123;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CHOLINERGIC ACTIVITY; CORTICAL THICKNESS (BRAIN); DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATONIGRAL DEGENERATION; TEMPORAL LOBE; WHITE MATTER; WHITE MATTER HYPERINTENSITY;

EID: 84898490229     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt248     Document Type: Review

References (69)

1. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. IG McKeith, DW Dickson, J Lowe, M Emre, JT O'Brien, H Feldman, J Cummings, JE Duda, C Lippa, EK Perry, D Aarsland, H Arai, CG Ballard, B Boeve, DJ Burn, D Costa, T Del Ser, B Dubois, D Galasko, S Gauthier, CG Goetz, E Gomez-Tortosa, G Halliday, LA Hansen, J Hardy, T Iwatsubo, RN Kalaria, D Kaufer, RA Kenny, A Korczyn, et al. Neurology 1863-1872 2005 65
2. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. MA Piggott, EF Marshall, N Thomas, S Lloyd, JA Court, E Jaros, D Burn, M Johnson, RH Perry, IG McKeith, C Ballard, EK Perry, Brain 1999 122 1449 1468 10.1093/brain/122.8.1449 10430831 (Pubitemid 29374123)
3. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. JT O'Brien, S Colloby, J Fenwick, ED Williams, M Firbank, D Burn, D Aarsland, IG McKeith, Arch Neurol 2004 61 919 925 10.1001/archneur.61.6.919 15210531 (Pubitemid 38747333)
4. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. I McKeith, J O'Brien, Z Walker, K Tatsch, J Booij, J Darcourt, A Padovani, R Giubbini, U Bonuccelli, D Volterrani, C Holmes, P Kemp, N Tabet, I Meyer, C Reininger, DLB Study Group, Lancet Neurol 2007 6 305 313 10.1016/S1474-4422(07) 70057-1 17362834 (Pubitemid 46367938)
5. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. Z Walker, E Jaros, RW Walker, L Lee, DC Costa, G Livingston, PG Ince, R Perry, I McKeith, CL Katona, J Neurol Neurosurg Psychiatry 2007 78 1176 1181 10.1136/jnnp.2006. 110122 17353255 (Pubitemid 350057277)
6. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. F Roselli, NM Pisciotta, R Perneczky, M Pennelli, MS Aniello, MF De Caro, E Ferrannini, B Tartaglione, G Defazio, G Rubini, P Livrea, Mov Disord 2009 24 2097 2103 10.1002/mds.22702 19705471
7. Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. JT O'Brien, IG McKeith, Z Walker, K Tatsch, J Booij, J Darcourt, M Marquardt, C Reininger, Br J Psychiatry 2009 194 34 39 10.1192/bjp.bp.108.052050 19118323
8. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. K Lobotesis, JD Fenwick, A Phipps, A Ryman, A Swann, C Ballard, IG McKeith, JT O'Brien, Neurology 2001 56 643 649 10.1212/WNL.56.5.643 11245717 (Pubitemid 32209999)
9. Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. S Minoshima, NL Foster, EC Petrie, RL Albin, KA Frey, DE Kuhl, J Geriatr Psychiatry Neurol 2002 15 200 209 10.1177/089198870201500405 12489916 (Pubitemid 35416166)
10. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT. H Hanyu, S Shimizu, K Hirao, H Kanetaka, H Sakurai, T Iwamoto, K Koizumi, K Abe, J Neurol Sci 2006 250 97 102 10.1016/j.jns.2006.07.007 17005204 (Pubitemid 44665937)
11. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. K Ishii, S Yamaji, H Kitagaki, T Imamura, N Hirono, E Mori, Neurology 1999 53 413 416 10.1212/WNL.53.2.413 10430439 (Pubitemid 29344372)
12. Covariance 99mTc-exametazime SPECT patterns in Alzheimer's disease and dementia with Lewy bodies: utility in differential diagnosis. SJ Colloby, JP Taylor, MJ Firbank, IG McKeith, ED Williams, JT O'Brien, J Geriatr Psychiatry Neurol 2010 23 54 62 10.1177/0891988709355272 20029055
13. Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis. SJ Colloby, JP Taylor, CM Davison, JJ Lloyd, MJ Firbank, IG McKeith, JT O'Brien, J Cereb Blood Flow Metab 2013 33 612 618 10.1038/jcbfm.2013.2 23361395
14. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. SJ Colloby, MJ Firbank, S Pakrasi, JJ Lloyd, I Driver, IG McKeith, ED Williams, JT O'Brien, Int Psychogeriatr 2008 20 1124 1140 10.1017/S1041610208007709 18752700
15. 'Parkinson-dementia' diseases: a comparison by double tracer SPECT studies. C Rossi, D Volterrani, V Nicoletti, G Manca, D Frosini, L Kiferle, E Unti, P De Feo, U Bonuccelli, R Ceravolo, Parkinsonism Relat Disord 2009 15 762 766 10.1016/j.parkreldis.2009.05.012 19553153
16. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. JC Klein, C Eggers, E Kalbe, S Weisenbach, C Hohmann, S Vollmar, S Baudrexel, NJ Diederich, WD Heiss, R Hilker, Neurology 2010 74 885 892 10.1212/WNL.0b013e3181d55f61 20181924
17. Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. R Perneczky, A Drzezga, H Boecker, H Forstl, A Kurz, P Haussermann, Dement Geriatr Cogn Disord 2008 25 531 538 10.1159/000132084 18477846 (Pubitemid 351957416)
18. Amyloid PET imaging in Lewy body disorders. P Donaghy, AJ Thomas, JT O'Brien, Am J Geriatr Psychiatry 2013 [Epub ahead of print]
19. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. P Edison, CC Rowe, JO Rinne, S Ng, I Ahmed, N Kemppainen, VL Villemagne, G O'Keefe, K Någren, KR Chaudhury, CL Masters, DJ Brooks, J Neurol Neurosurg Psychiatry 2008 79 1331 1338 10.1136/jnnp.2007.127878 18653550
20. Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson's disease. GM Halliday, YJ Song, AJ Harding, J Neural Transm 2011 118 713 719 10.1007/s00702-011-0641-6 21479514
21. Imaging beta-amyloid burden in aging and dementia. CC Rowe, S Ng, U Ackermann, SJ Gong, K Pike, G Savage, TF Cowie, KL Dickinson, P Maruff, D Darby, C Smith, M Woodward, J Merory, H Tochon-Danguy, G O'Keefe, WE Klunk, CA Mathis, JC Price, CL Masters, VL Villemagne, Neurology 2007 68 1718 1725 10.1212/01.wnl.0000261919.22630.ea 17502554 (Pubitemid 46763260)
22. Imaging amyloid deposition in Lewy body diseases. SN Gomperts, DM Rentz, E Moran, JA Becker, JJ Locascio, WE Klunk, CA Mathis, DR Elmaleh, T Shoup, AJ Fischman, BT Hyman, JH Growdon, KA Johnson, Neurology 2008 71 903 910 10.1212/01.wnl.0000326146.60732.d6 18794492
23. Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. V Kotagal, MLTM Müller, DI Kaufer, RA Koeppe, NI Bohnen, Neurosci Lett 2012 514 169 172 10.1016/j.neulet.2012.02.083 22414859
24. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. R Hilker, AV Thomas, JC Klein, S Weisenbach, E Kalbe, L Burghaus, AH Jacobs, K Herholz, WD Heiss, Neurology 2005 65 1716 1722 10.1212/01.wnl.0000191154.78131.f6 16344512
25. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. H Shimada, S Hirano, H Shinotoh, A Aotsuka, K Sato, N Tanaka, T Ota, M Asahina, K Fukushi, S Kuwabara, T Hattori, T Suhara, T Irie, Neurology 2009 73 273 278 10.1212/WNL.0b013e3181ab2b58 19474411
26. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. EK Perry, V Haroutunian, KL Davis, R Levy, P Lantos, S Eagger, M Honavar, A Dean, M Griffiths, IG McKeith, RH Perry, Neuroreport 1994 5 747 749 10.1097/00001756-199403000-00002 8018843 (Pubitemid 24133991)
27. Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease. S Gilman, RA Koeppe, R Little, H An, L Junck, B Giordani, C Persad, M Heumann, K Wernette, Ann Neurol 2004 55 774 780 10.1002/ana.20088 15174011 (Pubitemid 38702572)
28. Differentiating dementia with Lewy bodies and Alzheimer's disease using MRI. R Watson, JT O'Brien, Neurodegener Dis Manag 2012 2 411 420 10.2217/nmt.12.41
29. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. EJ Burton, R Barber, EB Mukaetova-Ladinska, J Robson, RH Perry, E Jaros, RN Kalaria, JT O'Brien, Brain 2009 132 195 203 19022858
30. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. F Barkhof, TM Polvikoski, EC van Straaten, RN Kalaria, R Sulkava, HJ Aronen, L Niinisto, S Rastas, M Oinas, P Scheltens, T Erkinjuntti, Neurology 2007 69 1521 1527 10.1212/01.wnl.0000277459.83543.99 17923614 (Pubitemid 47537859)
31. Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies. N Chow, D Aarsland, H Honarpisheh, MK Beyer, JH Somme, D Elashoff, A Rongve, OB Tysnes, PM Thompson, LG Apostolova, Dement Geriatr Cogn Disord 2012 34 44 50 10.1159/000339727 22922563
32. Application of the VSRAD, a specific and sensitive voxel-based morphometry, to comparison of entorhinal cortex atrophy between dementia with Lewy bodies and Alzheimer's disease. H Hayashi, S Kawakatsu, A Suzuki, Y Shibuya, R Kobayashi, C Sato, K Otani, Dement Geriatr Cogn Disord 2012 34 328 331 10.1159/000345792 23208522
33. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects. M Ballmaier, JT O'Brien, EJ Burton, PM Thompson, DE Rex, KL Narr, IG McKeith, H DeLuca, AW Toga, Neuroimage 2004 23 325 335 10.1016/j.neuroimage. 2004.04.026 15325380 (Pubitemid 39119463)
34. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. EJ Burton, G Karas, SM Paling, R Barber, ED Williams, CG Ballard, IG McKeith, P Scheltens, F Barkhof, JT O'Brien, Neuroimage 2002 17 618 630 10.1006/nimg.2002.1197 12377138 (Pubitemid 35316999)
35. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. JL Whitwell, SD Weigand, MM Shiung, BF Boeve, TJ Ferman, GE Smith, DS Knopman, RC Petersen, EE Benarroch, KA Josephs, CR Jack Jr, Brain 2007 130 708 719 10.1093/brain/awl388 17267521 (Pubitemid 46410745)
36. Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer's disease. H Hanyu, Y Tanaka, S Shimizu, H Sakurai, T Iwamoto, K Abe, J Neurol 2005 252 482 484 10.1007/s00415-005-0611-8 15772744 (Pubitemid 40576913)
37. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. K Kantarci, TJ Ferman, BF Boeve, SD Weigand, S Przybelski, P Vemuri, ME Murray, ML Senjem, GE Smith, DS Knopman, RC Petersen, CR Jack Jr, JE Parisi, DW Dickson, Neurology 2012 79 553 560 10.1212/WNL.0b013e31826357a5 22843258
38. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. DA Cousins, EJ Burton, D Burn, A Gholkar, IG McKeith, JT O'Brien, Neurology 2003 61 1191 1195 10.1212/01.WNL.0000091889.20347.30 14610119 (Pubitemid 37377536)
39. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. EJ Burton, IG McKeith, DJ Burn, ED Williams, JT O'Brien, Brain 2004 127 791 800 10.1093/brain/awh088 14749292 (Pubitemid 38478524)
40. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. MK Beyer, JP Larsen, D Aarsland, Neurology 2007 69 747 754 10.1212/01.wnl.0000269666.62598.1c 17709706 (Pubitemid 47300931)
41. A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry. JE Lee, B Park, SK Song, YH Sohn, HJ Park, PH Lee, Mov Disord 2010 25 28 34 10.1002/mds.22858 19908327
42. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia. C Sanchez-Castaneda, R Rene, B Ramirez-Ruiz, J Campdelacreu, J Gascon, C Falcon, M Calopa, S Jauma, M Juncadella, C Junque, Movement Disord 2010 25 615 622 10.1002/mds.22873 20175186
43. Multivariate classification of patients with Alzheimer's and dementia with Lewy bodies using high-dimensional cortical thickness measurements: an MRI surface-based morphometric study. AV Lebedev, E Westman, MK Beyer, MG Kramberger, C Aguilar, Z Pirtosek, D Aarsland, J Neurol 2013 260 1104 1115 10.1007/s00415-012-6768-z 23224109
44. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. R Barber, C Ballard, IG McKeith, A Gholkar, JT O'Brien, Neurology 2000 54 1304 1309 10.1212/WNL.54.6.1304 10746602 (Pubitemid 30174051)
45. Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. EJ Burton, IG McKeith, DJ Burn, MJ Firbank, JT O'Brien, Am J Geriatr Psychiatry 2006 14 842 849 10.1097/01.JGP.0000236596.56982.1c 17001024 (Pubitemid 44556478)
46. Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease. JE Galvin, JL Price, Z Yan, JC Morris, YI Sheline, Neurology 2011 76 1797 1803 10.1212/WNL.0b013e31821ccc83 21525427
47. Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison. R Franciotti, NW Falasca, L Bonanni, F Anzellotti, V Maruotti, S Comani, A Thomas, A Tartaro, J-P Taylor, M Onofrj, Neurobiol Aging 2013 34 1148 1158 10.1016/j.neurobiolaging. 2012.09.015 23063646
48. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. MD Greicius, G Srivastava, AL Reiss, V Menon, Proc Natl Acad Sci U S A 2004 101 4637 4642 10.1073/pnas. 0308627101 15070770 (Pubitemid 38437463)
49. Subcortical connectivity in dementia with Lewy bodies and Alzheimer's disease. ER Kenny, JT O'Brien, MJ Firbank, AM Blamire, Br J Psychiatry 2013 203 209 214 10.1192/bjp.bp.112.108464 23846997
50. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. J Sauer, DH Ffytche, C Ballard, RG Brown, R Howard, Brain 2006 129 1780 1788 10.1093/brain/awl102 16670180 (Pubitemid 43999411)
51. Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study. JP Taylor, MJ Firbank, J He, N Barnett, S Pearce, A Livingstone, Q Vuong, IG McKeith, JT O'Brien, Br J Psychiatry 2012 200 491 498 10.1192/bjp.bp.111. 099432 22500014
52. MR diffusion tensor spectroscopy and imaging. PJ Basser, J Mattiello, D LeBihan, Biophys J 1994 66 259 267 10.1016/S0006-3495(94)80775-1 8130344 (Pubitemid 24016507)
53. Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies. MJ Firbank, AM Blamire, A Teodorczuk, E Teper, D Mitra, JT O'Brien, Psychiatry Res 2011 194 176 183 10.1016/j.pscychresns.2011.08.002 21955457
54. Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. K Kantarci, R Avula, ML Senjem, AR Samikoglu, B Zhang, SD Weigand, SA Przybelski, HA Edmonson, P Vemuri, DS Knopman, TJ Ferman, BF Boeve, RC Petersen, CR Jack Jr, Neurology 1814-1821 2010 74
55. Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging. M Ota, N Sato, M Ogawa, M Murata, S Kuno, J Kida, T Asada, NMR Biomed 2009 22 280 284 10.1002/nbm.1321 19009555
56. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. R Watson, AM Blamire, SJ Colloby, JS Wood, R Barber, J He, JT O'Brien, Neurology 2012 79 906 914 10.1212/WNL.0b013e318266fc51 22895591
57. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. MJ Firbank, RM Harrison, JT O'Brien, Dement Geriatr Cogn Disord 2002 14 64 76 10.1159/000064927 12145453 (Pubitemid 36152947)
58. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. F Jessen, W Block, F Traber, E Keller, S Flacke, A Papassotiropoulos, R Lamerichs, R Heun, HH Schild, Neurology 2000 55 684 688 10.1212/WNL.55.5.684 10980734
59. 1H MR spectroscopy in common dementias. K Kantarci, RC Petersen, BF Boeve, DS Knopman, DF Tang-Wai, PC O'Brien, SD Weigand, SD Edland, GE Smith, RJ Ivnik, TJ Ferman, EG Tangalos, CR Jack Jr, Neurology 2004 63 1393 1398 10.1212/01.WNL.0000141849.21256.AC 15505154
60. Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. C Davatzikos, SM Resnick, X Wu, P Parmpi, CM Clark, Neuroimage 2008 41 1220 1227 10.1016/j.neuroimage.2008.03.050 18474436
61. Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND. P Vemuri, G Simon, K Kantarci, JL Whitwell, ML Senjem, SA Przybelski, JL Gunter, KA Josephs, DS Knopman, BF Boeve, TJ Ferman, DW Dickson, JE Parisi, RC Petersen, CR Jack Jr, Neuroimage 2011 55 522 531 10.1016/j.neuroimage.2010.12.073 21195775
62. Multimodal imaging in mild cognitive impairment: metabolism, morphometry and diffusion of the temporal-parietal memory network. KB Walhovd, AM Fjell, I Amlien, R Grambaite, V Stenset, A Bjornerud, I Reinvang, L Gjerstad, T Cappelen, P Due-Tonnessen, T Fladby, Neuroimage 2009 45 215 223 10.1016/j.neuroimage. 2008.10.053 19056499
63. A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables. C Luckhaus, M Jänner, M Cohnen, MO Flüss, SJ Teipel, M Grothe, H Hampel, J Kornhuber, E Rüther, O Peters, T Supprian, W Gaebel, U Mödder, HJ Wittsack, Eur J Neurol 2010 17 1437 1444 10.1111/j.1468-1331.2010.03038.x 20443979
64. Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging. D Tosun, P Mojabi, MW Weiner, N Schuff, Neuroimage 2010 52 186 197 10.1016/j.neuroimage.2010.04.033 20406691
65. Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. J Dukart, K Mueller, A Horstmann, H Barthel, HE Moller, A Villringer, O Sabri, ML Schroeter, PLoS One 2011 6 18111 10.1371/journal.pone.0018111 21448435
66. Multimodal classification of Alzheimer's disease and mild cognitive impairment. D Zhang, Y Wang, L Zhou, H Yuan, D Shen, Neuroimage 2011 55 856 867 10.1016/j.neuroimage.2011.01.008 21236349
67. Differential diagnosis of dementia with Lewy Bodies and Alzheimer Disease using combined MR imaging and brain perfusion single-photon emission tomography. H Goto, K Ishii, T Uemura, N Miyamoto, T Yoshikawa, K Shimada, S Ohkawa, AJNR Am J Neuroradiol 2010 31 720 725 10.3174/ajnr.A1926 20075101
68. Multimodality imaging characteristics of Dementia with Lewy bodies. K Kantarci, VJ Lowe, BF Boeve, SD Weigand, ML Senjem, SA Przybelski, DW Dickson, JE Parisi, DS Knopman, GE Smith, TJ Ferman, RC Petersen, CR Jack Jr, Neurobiol Aging 2012 33 2091 2105 10.1016/j.neurobiolaging.2011.09.024 22018896
69. Rates of cerebral atrophy differ in different degenerative pathologies. JL Whitwell, CR Jack Jr, JE Parisi, DS Knopman, BF Boeve, RC Petersen, TJ Ferman, DW Dickson, KA Josephs, Brain 2007 130 1148 1158 17347250 (Pubitemid 47355599)